FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 8.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $100,000 | +7.5% | 2,646 | -51.8% | 0.00% | – |
| Q4 2020 | $93,000 | +287.5% | 5,492 | +5.4% | 0.00% | – |
| Q3 2020 | $24,000 | -36.8% | 5,211 | -18.2% | 0.00% | – |
| Q2 2020 | $38,000 | +153.3% | 6,367 | -9.1% | 0.00% | – |
| Q1 2020 | $15,000 | -59.5% | 7,001 | -13.9% | 0.00% | – |
| Q4 2019 | $37,000 | -11.9% | 8,131 | -25.0% | 0.00% | – |
| Q3 2019 | $42,000 | -12.5% | 10,844 | +35.6% | 0.00% | – |
| Q2 2019 | $48,000 | -86.1% | 7,998 | -68.9% | 0.00% | – |
| Q1 2019 | $345,000 | +202.6% | 25,748 | +110.4% | 0.00% | – |
| Q4 2018 | $114,000 | -33.3% | 12,238 | 0.0% | 0.00% | – |
| Q3 2018 | $171,000 | -7.6% | 12,238 | +4.8% | 0.00% | – |
| Q2 2018 | $185,000 | -15.5% | 11,676 | -8.6% | 0.00% | – |
| Q1 2018 | $219,000 | -26.5% | 12,768 | -5.8% | 0.00% | – |
| Q4 2017 | $298,000 | -28.4% | 13,558 | +31.9% | 0.00% | – |
| Q3 2017 | $416,000 | +44.4% | 10,281 | +8.7% | 0.00% | – |
| Q2 2017 | $288,000 | -13.0% | 9,455 | +3.1% | 0.00% | – |
| Q1 2017 | $331,000 | -0.3% | 9,168 | +39.2% | 0.00% | – |
| Q4 2016 | $332,000 | +71.1% | 6,585 | +75.5% | 0.00% | – |
| Q3 2016 | $194,000 | +14.8% | 3,752 | -8.0% | 0.00% | – |
| Q2 2016 | $169,000 | +5.6% | 4,077 | +5.4% | 0.00% | – |
| Q1 2016 | $160,000 | +16.8% | 3,869 | +15.8% | 0.00% | – |
| Q4 2015 | $137,000 | +168.6% | 3,342 | 0.0% | 0.00% | – |
| Q3 2015 | $51,000 | -37.0% | 3,342 | 0.0% | 0.00% | – |
| Q2 2015 | $81,000 | +2.5% | 3,342 | 0.0% | 0.00% | – |
| Q1 2015 | $79,000 | -12.2% | 3,342 | 0.0% | 0.00% | – |
| Q4 2014 | $90,000 | +125.0% | 3,342 | 0.0% | 0.00% | – |
| Q3 2014 | $40,000 | – | 3,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|